Wednesday, September 20, 2006
Do the principles of marketing differ so differently from industry to industry? What is it in pharma that makes marketing so difficult? Is it because this is a vastly regulated industry or is it because we cannot get to the end consumer (at least in India)?. Why do we not see any pathbreaking campaigns or case-study kind of marketing approaches. Why is it that none of what we do in pharma gets published in HBR? Why is it that pharma marketers dread to veer from the treaded path? Why??!